Aurora Cannabis Inc. - stock earnings
ACB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -18.5 million USD | 48.6 million USD |
| 2023Q3 | -1.6 million USD | 46.7 million USD |
| 2023Q2 | -467.4 million USD | 37.9 million USD |
| 2023Q1 | 347.7 million USD | 53.3 million USD |
| 2022Q4 | -48.2 million USD | 45.5 million USD |
| 2022Q3 | -37.7 million USD | 35.9 million USD |
| 2022Q2 | -479.6 million USD | 38.9 million USD |
| 2022Q1 | -808.6 million USD | 40.3 million USD |
| 2021Q4 | -59.4 million USD | 47.9 million USD |
| 2021Q3 | -9.4 million USD | 47.4 million USD |
| 2021Q2 | -103.4 million USD | 44.1 million USD |
| 2021Q1 | -131.1 million USD | 43.9 million USD |
| 2020Q4 | -230.0 million USD | 53.2 million USD |
| 2020Q3 | -81.2 million USD | 51.0 million USD |
| 2020Q2 | -1.4 billion USD | 53.1 million USD |
| 2020Q1 | -96.9 million USD | 53.3 million USD |
| 2019Q4 | -984.8 million USD | 42.9 million USD |
| 2019Q3 | 9.7 million USD | 57.1 million USD |
| 2019Q2 | -147413 USD | 75.6 million USD |
| 2019Q1 | -117.9 million USD | 48.5 million USD |
| 2018Q4 | -174.5 million USD | 39.8 million USD |
| 2018Q3 | 80.9 million USD | 22.8 million USD |
| 2018Q2 | 60.3 million USD | 14.4 million USD |
| 2018Q1 | -14.9 million USD | 12.5 million USD |
| 2017Q4 | 6.1 million USD | 9.3 million USD |
| 2017Q3 | 2.9 million USD | 6.6 million USD |
| 2017Q2 | -3.7 million USD | 4.6 million USD |
| 2017Q1 | 104142 USD | 3.9 million USD |
| 2016Q4 | -2.0 million USD | 2.9 million USD |
| 2016Q3 | -4.3 million USD | 2.3 million USD |
| 2016Q2 | -5.8 million USD | 943672 USD |
| 2016Q1 | 1.9 million USD | 168953 USD |
| 2015Q4 | 427388 USD | ? USD |
| 2015Q3 | -1.0 million USD | ? USD |
| 2015Q2 | 23.6 million USD | -14914 USD |
| 2015Q1 | -610181 USD | ? USD |
| 2014Q4 | -5.4 million USD | ? USD |
| 2014Q3 | -455498 USD | ? USD |
| 2014Q2 | -223083 USD | ? USD |
| 2014Q1 | -84140 USD | ? USD |
| 2013Q4 | -27345 USD | ? USD |
| 2013Q3 | -38548 USD | ? USD |
| 2013Q2 | -100642 USD | ? USD |
| 2013Q1 | -71914 USD | ? USD |
| 2012Q4 | -68491 USD | ? USD |
| 2012Q3 | -151844 USD | ? USD |
| 2012Q2 | -191766 USD | ? USD |
| 2012Q1 | -41795 USD | ? USD |
| 2011Q4 | -34432 USD | ? USD |
| 2011Q3 | -39371 USD | ? USD |
| 2011Q2 | -56611 USD | ? USD |
| 2011Q1 | -227303 USD | ? USD |
| 2010Q4 | -12621 USD | ? USD |
| 2010Q3 | -33239 USD | ? USD |
| 2010Q2 | -45007 USD | ? USD |
| 2010Q1 | -26078 USD | ? USD |
| 2009Q4 | -9711 USD | ? USD |
| 2009Q3 | -16780 USD | ? USD |
| 2009Q2 | -15147 USD | 35152 USD |
| 2009Q1 | -23500 USD | ? USD |
| 2008Q4 | -18292 USD | ? USD |
| 2008Q3 | -71566 USD | ? USD |
| 2008Q2 | -22033 USD | ? USD |
| 2008Q1 | -4560 USD | ? USD |
| 2007Q4 | -150840 USD | ? USD |
| 2007Q3 | 205 USD | ? USD |
ACB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -200.4 million USD | 176.2 million USD |
| 2022 | -1.3 billion USD | 171.7 million USD |
| 2021 | -559.6 million USD | 197.9 million USD |
| 2020 | -2.4 billion USD | 205.5 million USD |
| 2019 | -222.1 million USD | 189.4 million USD |
| 2018 | 54.3 million USD | 41.6 million USD |
| 2017 | -10.0 million USD | 13.9 million USD |
| 2016 | -4.4 million USD | 1.1 million USD |
| 2015 | -7.7 million USD | ? USD |
| 2014 | -374816 USD | ? USD |
| 2013 | -375679 USD | ? USD |
| 2012 | -305567 USD | ? USD |
| 2011 | -333435 USD | ? USD |
| 2010 | -41334 USD | ? USD |
| 2009 | -125392 USD | 35152 USD |
| 2008 | -173918 USD | ? USD |
| 2007 | 1190 USD | ? USD |
ACB
Price: $6.42
52 week price:
Earnings Per Share: -57.84 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 13.9 million
Market Capitalization: 350.3 million